Directed Learning eCourse


Share

Program Content

Activities

  • BTK Inhibitors in CLL/SLL and MCL
    Key Considerations for the Individualizing Use of BTK Inhibitors in B-Cell Malignancies
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 11, 2023

    Expires: October 10, 2024

Faculty

cover img faculity

Matthew S. Davids, MD, MMSc

Director of Clinical Research
Division of Lymphoma
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Josie Montegaard, MSN, AGPCNP-BC

Nurse Practitioner
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca